Extremely helpful again. My informal take on the Ivermectin literature, having been one of the lead statisticians on two Ivermectin RCTs, is that Ivermectin has a beneficial effect that happens to be very small, almost inconsequential. This matches a meta-analyses of RCTs we were not involved in. We need to do more inference on a clinical scale. In our case we compute a Bayesian posterior probability that patients recovered from COVID-19 more than 1/2 day quicker with Ivermectin than with placebo.
1 Like